FIELD: chemistry.
SUBSTANCE: present invention discloses pharmaceutical compositions based on telozolomide-8-carboxylate compounds of general formula I, as well as a method of preparing the said compositions. The disclosed composition has anti-tumour activity and can be especially useful during transdermal application.
EFFECT: obtaining compositions which, along with conventional pharmaceutical carriers, contain a component of acidic nature which gives the pharmaceutical composition high resistance to pH fluctuation.
16 cl, 2 tbl, 21 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ARYL-CONDENSED ISOSELENAZOLE COMPOUND CONTAINING TETRAZINE SUBSTITUTE, METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2021 |
|
RU2818486C1 |
| PHARMACEUTICAL COMPOSITION BASED ON 3-(4-METHYLIMIDAZOLE-1-YL)IMIDAZO[1,2-b][1,2,4,5]TETRAZINE AS ANTI-TUMOR AGENT | 2015 |
|
RU2614234C2 |
| PHARMACEUTICAL COMPOSITION SHOWING ANTITUMOR ACTIVITY AND METHOD OF ITS PREPARING | 1994 |
|
RU2148401C1 |
| PYRIMIDYL CYCLOPENTANES AS AKT-PROTEIN KINASE INHIBITORS | 2008 |
|
RU2486178C2 |
| TRANSDERMAL COMPOSITION CONTAINING DONEPEZIL AS ACTIVE INGREDIENT | 2015 |
|
RU2713207C2 |
| HYDROXYLATED PYRIMIDYL CYCLOPENTANE AS PROTEINKINASE (ACT) INHIBITOR | 2009 |
|
RU2520735C2 |
| COMBINATIONS OF ALPHA-2-DELTA-LIGAND WITH SELECTIVE CYCLOIXYGENASE-2 INHIBITOR | 2003 |
|
RU2286151C2 |
| SUBSTITUTED QUINOLINE COMPOUNDS AND METHODS OF THEIR APPLICATION | 2012 |
|
RU2568258C2 |
| COMBINATIONS OF AKT INHIBITOR COMPOUNDS AND ABIRATERONE, AND APPLICATION METHODS | 2012 |
|
RU2631240C2 |
| HYDROXYLATED PYRIMIDYLCYCLOPENTANES AS PROTEIN KINASE (AKT) INHIBITORS | 2009 |
|
RU2504542C2 |
